Works matching DE "INFLAMMATORY bowel disease treatment"


Results: 2696
    1
    2

    New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases.

    Published in:
    International Journal of Integrated Care (IJIC), 2025, v. 25, n. 2, p. 1, doi. 10.5334/ijic.7741
    By:
    • Chamorro-de-Vega, Esther;
    • González, C. M.;
    • Menchén, L.;
    • Baniandrés, O.;
    • Herranz, A.;
    • Lobo-Rodríguez, C.;
    • Romero-Jiménez, R.;
    • Ais-Larisgoitia, A.;
    • Lobato-Matilla, E.;
    • López-Esteban, A.;
    • López-Calleja, A.;
    • Marín-Jiménez, I.;
    • Monteagudo, I.;
    • de Los Ríos, P. Morales;
    • Nieto, J. C.;
    • Ferris-Villanueva, M.;
    • Lizcano, M. J.;
    • Simón Moreno, M. P.;
    • Sanjurjo, M.;
    • de Sanjosé, S. García
    Publication type:
    Article
    3

    Cutaneous side effects caused by treatment for inflammatory bowel disease.

    Published in:
    Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2016, v. 73, n. 4, p. 382, doi. 10.2298/VSP151123023D
    By:
    • Tarabar, Dino;
    • Sekulović, Lidija Kandolf;
    • Tatomirović, Željka;
    • Mijušković, Željko;
    • Milenković, Zoran;
    • Tarabar, Olivera;
    • Broćić, Tanja Pecelj
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Practical management of inflammatory bowel disease patients during the COVID‐19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.

    Published in:
    Internal Medicine Journal, 2020, v. 50, n. 7, p. 798, doi. 10.1111/imj.14889
    By:
    • Aysha, Al‐Ani;
    • Rentsch, Clarissa;
    • Prentice, Ralley;
    • Johnson, Doug;
    • Bryant, Robert V.;
    • Ward, Mark G.;
    • Costello, Samuel P.;
    • Lewindon, Peter;
    • Ghaly, Simon;
    • Connor, Susan J.;
    • Begun, Jakob;
    • Christensen, Britt
    Publication type:
    Article
    41
    42
    43

    Cost-minimization and budget impact analysis of certolizumab pegol for patients with Crohn's disease, moderate or severe, with relapse after conventional treatment from the perspective of the Brazilian private payer.

    Published in:
    JBES: Brazilian Journal of Health Economics / Jornal Brasileiro de Economia da Saúde, 2017, v. 9, n. 1, p. 44, doi. 10.21115/JBES.v9.n1.p44-53
    By:
    • Rosim, Ricardo Papaléo;
    • de Souza Duva, Andreas;
    • Ballalai Ferraz, André Fabre;
    • Valle, Arcangela;
    • Tóth, Emese;
    • Ferguson, Samara;
    • Carmo, Érico V. S.
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50